{
    "eid": "2-s2.0-85032798826",
    "title": "Lipid Peroxidation and Immune Biomarkers Are Associated with Major Depression and Its Phenotypes, Including Treatment-Resistant Depression and Melancholia",
    "cover-date": "2018-02-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Neuroscience (all)",
            "@code": "2800",
            "@abbrev": "NEUR"
        },
        {
            "@_fa": "true",
            "$": "Toxicology",
            "@code": "3005",
            "@abbrev": "PHAR"
        }
    ],
    "keywords": [
        "Cytokines",
        "Immune",
        "Inflammation",
        "Major depression",
        "Melancholia",
        "Oxidative stress"
    ],
    "authors": [
        "Magdalena Sowa-Ku\u0107ma",
        "Krzysztof Stycze\u0144",
        "Marcin Siwek",
        "Paulina Misztak",
        "Rafa\u0142 J. Nowak",
        "Dominika Dudek",
        "Janusz K. Rybakowski",
        "Gabriel Nowak",
        "Michael Maes"
    ],
    "citedby-count": 45,
    "ref-count": 70,
    "ref-list": [
        "Biological role of interleukin 1 receptor antagonist isoforms",
        "Comparison of pro-inflammatory cytokines among patients with bipolar disorder and unipolar depression and normal controls",
        "Oxidative stress and major depression",
        "Increased plasma levels of soluble TNF receptor I in patients with bipolar disorder",
        "Inflammation and treatment response to sertraline in patients with coronary heart disease and comorbid major depression",
        "The plasma levels of various cytokines are increased during ongoing depression and are reduced to normal levels after recovery",
        "A clinical perspective of IL-1\u03b2 as the gatekeeper of inflammation",
        "Increased soluble TNF receptor 2 in antidepressant-free patients with late-life depression",
        "A meta-analysis of cytokines in major depression",
        "Melancholic and atypical major depression\u2014connection between cytokines, psychopathology and treatment",
        "Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission",
        "Oxidative stress parameters after combined fluoxetine and acetylsalicylic acid therapy in depressive patients",
        "A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression",
        "Increased soluble tumor necrosis factor-alpha receptors in patients with major depressive disorder",
        "Cumulative meta-analysis of interleukins 6 and 1\u03b2, tumour necrosis factor \u03b1 and C-reactive protein in patients with major depressive disorder",
        "A rating scale for depression",
        "The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis",
        "A meta-analysis of differences in IL-6 and IL-10 between people with and without depression: exploring the causes of heterogeneity",
        "Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis",
        "The role of interleukin-1 in the pathogenesis of rheumatoid arthritis",
        "Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies",
        "Cytokine production and treatment response in major depressive disorder",
        "Serum anti-inflammatory markers in general population subjects with elevated depressive symptoms",
        "Interleukin (IL)-6, tumor necrosis factor alpha (TNF-\u03b1) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression",
        "A meta-analysis of oxidative stress markers in depression",
        "Depression is an inflammatory disease, but cell-mediated immune activation is the key component of depression",
        "Immune disturbances during major depression: upregulated expression of interleukin-2 receptors",
        "Depression-related disturbances in mitogen-induced lymphocyte responses and interleukin-1 beta and soluble interleukin-2 receptor production",
        "Evidence for a systemic immune activation during depression: results of leukocyte enumeration by flow cytometry in conjunction with monoclonal antibody staining",
        "Disturbances in acute phase plasma proteins during melancholia: additional evidence for the presence of an inflammatory process during that illness",
        "Increased neopterin and interferon-gamma secretion and lower availability of L-tryptophan in major depression: further evidence for an immune response",
        "Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression",
        "Increased serum interleukin-1-receptor-antagonist concentrations in major depression",
        "Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression",
        "Elevated serum interleukin-6 (IL-6) and IL-6 receptor concentrations in posttraumatic stress disorder following accidental man-made traumatic events",
        "The inflammatory response following delivery is amplified in women who previously suffered from major depression, suggesting that major depression is accompanied by a sensitization of the inflammatory response system",
        "A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness",
        "Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways",
        "Activation of cell-mediated immunity in depression: association with inflammation, melancholia, clinical staging and the fatigue and somatic symptom cluster of depression",
        "Targeting IL-1 in depression",
        "Increased autoimmune responses against auto-epitopes modified by oxidative and nitrosative damage in depression: implications for the pathways to chronic depression and neuroprogression",
        "Targeting classical IL-6 signalling or IL-6 trans-signalling in depression?",
        "Toward omics-based, systems biomedicine, and path and drug discovery methodologies for depression-inflammation research",
        "Peripheral oxidative damage in early-stage mood disorders: anested population-based case-control study",
        "Increased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosis",
        "Interleukin-1 receptor antagonist and incident depressive symptoms over 6 years in older persons: the InCHIANTI study",
        "A new depression scale designed to be sensitive to change",
        "In patients with heart failure elevated soluble TNF-receptor 1 is associated with higher risk of depression",
        "In patients with stable heart failure, soluble TNF-receptor 2 is associated with increased risk for depressive symptoms",
        "Oxidative & nitrosative stress in depression: why so much stress?",
        "Depressive symptomatology is associated with decreased interleukin-1 beta and increased interleukin-1 receptor antagonist levels in males",
        "IL-1 receptor antagonist in metabolic diseases: Dr Jekyll or Mr Hyde?",
        "Immunological differences between patients with major depression and somatization syndrome",
        "Abnormal gene expression of proinflammatory cytokines and their membrane-bound receptors in the lymphocytes of depressed patients",
        "The relationships among acculturation, body mass index, depression, and interleukin 1-receptor antagonist in Hispanic pregnant women",
        "TNF and TNF-receptors: from mediators of cell death and inflammation to therapeutic giants\u2014past, present and future",
        "Cytokine production and serum proteins in depression",
        "Multifaceted inhibition of anti-tumour immune mechanisms by soluble tumor necrosis factor receptor type I",
        "Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depression",
        "Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine",
        "Production of IL-1 and its receptor antagonist is regulated differently by IFN-gamma and IL-4 in human monocytes and alveolar macrophages",
        "The inflammatory response system and the availability of plasma tryptophan in patients with primary sleep disorders and major depression",
        "The serum magnesium concentration as a potential state marker in patients with unipolar depressive disorder",
        "The serum zinc concentration as a potential biological marker in patients with major depressive disorder",
        "Reduction of arthritis and pneumonitis in motheaten mice by soluble tumor necrosis factor receptor",
        "Evidence for sustained elevation of IL-6 in the CNS as a key contributor of depressive-like phenotypes",
        "Increased plasma levels of soluble TNF receptors 1 and 2 in bipolar depression and impact of lithium treatment",
        "CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies",
        "Role of cytokines in atypical depression"
    ],
    "affiliation": [
        {
            "affiliation-city": "Krakow",
            "@id": "60021323",
            "affilname": "Jagiellonian University Medical College",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60021323",
            "affiliation-country": "Poland"
        },
        {
            "affiliation-city": "Poznan",
            "@id": "60069010",
            "affilname": "Poznan University of Medical Sciences",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60069010",
            "affiliation-country": "Poland"
        },
        {
            "affiliation-city": "Plovdiv",
            "@id": "60031890",
            "affilname": "Medical University of Plovdiv",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031890",
            "affiliation-country": "Bulgaria"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Londrina",
            "@id": "60027866",
            "affilname": "Universidade Estadual de Londrina",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60027866",
            "affiliation-country": "Brazil"
        },
        {
            "affiliation-city": "Geelong",
            "@id": "60018805",
            "affilname": "Deakin University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018805",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Rzeszow",
            "@id": "60007672",
            "affilname": "University of Rzesz\u00f3w",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60007672",
            "affiliation-country": "Poland"
        },
        {
            "affiliation-city": "Krakow",
            "@id": "60000995",
            "affilname": "Institute of Pharmacology of the Polish Academy of Sciences",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60000995",
            "affiliation-country": "Poland"
        },
        {
            "affiliation-city": "Waalre",
            "@id": "116324567",
            "affilname": "Revitalis",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/116324567",
            "affiliation-country": "Netherlands"
        }
    ],
    "funding": [
        "Institute of Pharmacology",
        "Polish Academy of Sciences and Jagiellonian University Medical College, Krak\u00f3w, Poland",
        "European Regional Development Fund"
    ]
}